Does the microaneurysm have to be distinguished from a similar-sized dot hemorrhage?  

作　　者：Yueqing He Xi Huang Sheng Gao Meixia Zhang Junjun Zhang 

机构地区：[1]Department of Ophthalmology,Beijing Tongren Hospital,Capital Medical University,Beijing 100005,China [2]Department of Ophthalmology and Laboratory of Macular disease,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China [3]Chengdu AIDI Eye Hospital,Chengdu,Sichuan 610072,China.

出　　处：《Chinese Medical Journal》2024年第20期2504-2506,共3页中华医学杂志(英文版)

基　　金：supported in part by the Sichuan Provincial Science and Technology Support Project(Nos.2022YFS0192 and 2021YFS0213).

摘　　要：To the Editor:China now has the largest number of patients with diabetes mellitus(DM)worldwide,making diabetic retinopathy(DR)the leading cause of blindness in the Chinese working-age population.[1]Fundus screening for patients with DM is important so that ophthalmologists treat retinopathy in a timely manner and delay the development of vision loss.However,we found some problems in the clinical practice of fundus screening.Microaneurysm(MA)and small dot intraretinal hemorrhage(HEM),although described precisely by the Early Treatment Diabetic Retinopathy Study(ETDRS)group,[2]are red and round spots on dilated ophthalmoscopy and cannot be easily differentiated due to incompletely transparent dioptric media of patients unless fundus fluorescein angiography(FFA)is performed.Questions always come up:Do we have to differentiate these two lesions when grading the severity of DR?

关 键 词：ANEURYSM HEMORRHAGE sized 

分 类 号：R58[医药卫生—内分泌]